A PHASE I/II STUDY OF ERLOTINIB IN COMBINATION WITH THE ANTI-INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR (IGF-1R) MONOCLONAL ANTIBODY IMC-A12 (CIXUTUMUMAB) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC). Conference Paper uri icon

authors

  • Weickhardt, Andrew J
  • Doebele, Robert C
  • Oton, Anna B
  • Dy, Grace
  • Lettieri, Jannice
  • Maxson, Delee A
  • Reynolds, Michelle
  • Jackson, Mary K
  • Brown, Amy
  • Adjei, Araba
  • Fetterly, Gerald J
  • Adjei, Alex A
  • Camidge, David R

publication date

  • June 1, 2011